Houston, TX - November 17, 2010 – Capital Royalty L.P. (“Capital Royalty”) announced today that it has established a Strategic Advisory Committee (“SAC”) comprised of world-class leaders with extensive experience in building global biopharmaceutical companies, managing large scale research and development initiatives, and developing national healthcare policies. Capital Royalty’s SAC was created to support the firm’s investment team in identifying emerging industry trends, broadening industry relationships around the globe, and evaluating new investment opportunities.
Sidney Taurel, a Senior Advisor at Capital Royalty, is Chairman of the SAC and responsible for leading and directing the activities of the SAC. Mr. Taurel is joined…Read More »
Houston, TX - May 20, 2010 – Capital Royalty L.P. (“Capital Royalty”) announced today that Mike Weinmann has been promoted to Managing Director. Mr. Weinmann leads Capital Royalty’s New York office, where his responsibilities include identifying, structuring, and leading due diligence on royalty monetization transactions. Mr. Weinmann is also a member of the firm’s Investment Committee.
“Mike has been an invaluable asset to Capital Royalty since joining the Firm as a Principal in March of 2009. Mr. Weinmann’s commanding knowledge of the royalty space, intimate involvement in the creation of the royalty bond product, and extensive industry relationships have…Read More »
Houston, TX - March 22, 2010 – Capital Royalty L.P. (“Capital Royalty”) announced today that it continues to expand and strengthen its royalty investment team with three new appointments – Andrei Dorenbaum as General Counsel and Executive Director, Peter Faroni as Associate, and James Tate as Analyst. Mr. Dorenbaum will operate out of the Firm’s Houston headquarters, while Messrs. Faroni and Tate will join Mike Weinmann in the Firm’s New York office.
As Capital Royalty’s General Counsel and Executive Director, Mr. Dorenbaum brings over fifteen years of legal and transaction experience, most recently as Assistant General Counsel at Highland…Read More »
-- Former Eli Lilly & Co. CEO and Chariman Brings Global Healthcare Industry Perspective, Experience and Relationships to Capital Royalty's Healthcare Financing Team --
Houston, TX - March 2, 2010 – Capital Royalty L.P. (“Capital Royalty”) announced today that effective immediately, Sidney Taurel, a recognized global pharmaceutical veteran and innovator, has joined the firm as a Senior Advisor. Mr. Taurel also will Chair Capital Royalty’s newly-established Strategic Advisory Committee (“SAC”).
Mr. Taurel brings a lifetime career of pharmaceutical industry experience and leadership, including 37 years at Eli Lilly and Co. where he served successively as President of Lilly…Read More »